Filter Results:
(373)
Show Results For
- All HBS Web
(373)
- News (76)
- Research (279)
- Events (9)
- Multimedia (1)
- Faculty Publications (138)
Show Results For
- All HBS Web
(373)
- News (76)
- Research (279)
- Events (9)
- Multimedia (1)
- Faculty Publications (138)
- 10 Mar 2008
- Research & Ideas
Encouraging Entrepreneurs: Lessons for Government Policy
own business—even if that business may have failed." Nanda and Sørensen control for the possibility that former and aspiring entrepreneurs are more likely to cluster together at a company with an entrepreneurial culture,... View Details
Keywords: by Julia Hanna
- 05 May 2020
- News
“Walking a Tightrope”
age of innovation. There are people all over the country in universities and colleges who are actually doing research and conducting randomized control trials to determine what... View Details
- 17 Sep 2013
- First Look
First Look: September 17
recommendations for stocks with larger market capitalizations and lower return volatility than their sell-side peers, consistent with their facing fewer conflicts of interest and having a preference for liquid stocks. Tests with no View Details
Keywords: Sean Silverthorne
- 19 Sep 2024
- Blog Post
A Day at Royal FloraHolland: The Epicenter of the Global Flower Market
overlook the significance of these certifications and typically lack the necessary operational capacity to pursue them, underscoring a divide in the adoption of sustainable practices within the RFH community. RFH also champions eco-friendly cultivation methods, such as... View Details
- 10 Mar 2014
- Research & Ideas
Counting Up the Effects of Sarbanes-Oxley
approach when considering SOX," explains Srinivasan. The most worrisome part of the act on the business side was the mandate that required public companies to obtain an independent audit of their internal control practices. The cost... View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
substantial variation exists across organizations with regard to management, suggesting frictions in the broader diffusion of management knowledge. We argue that peer networks may allow for the diffusion of productive management across firms. Using a View Details
Keywords: Carmen Nobel
- 20 Sep 2011
- First Look
First Look: September 20
likelihood that they will exploit their current exchange partners, even after controlling for the leverage provided by the outside options. Our results demonstrate that previously sunken investments lead to a heightened sense of... View Details
Keywords: Sean Silverthorne
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx. The potential of this technology... View Details
- 21 Apr 2009
- First Look
First Look: April 21, 2009
season. We first document relatively low levels of adoption of this new risk management technology: only 5%-10% of households purchase insurance, even though rainfall variability is overwhelmingly cited by households as the most important risk they face. We then... View Details
Keywords: Martha Lagace
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- January 2009 (Revised July 2009)
- Case
Targanta Therapeutics: Hitting a Moving Target
By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
- 01 Dec 2020
- News
Tried and Tested
have control over that. When employees don’t have control over something that matters to them, this usually points toward potential policy interventions and also naturally occurring interventions that we can... View Details
- 07 Oct 2014
- First Look
First Look: October 7
the evaluations given (and consequent resource allocation). We empirically evaluate effects in data collected from a grant proposal process at a leading research university in which we randomized the assignment of evaluators and proposals... View Details
Keywords: Sean Silverthorne
- 20 Feb 2008
- First Look
First Look: February 20, 2008
despite export options which appear to be more profitable. Thus many conjecture that one or several markets are missing. We report here on a randomized controlled trial... View Details
Keywords: Martha Lagace
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
facilities detect and control outbreaks of health care–associated infections. Lee notes that services like epiXact are not DZD’s primary objective, but they are critical to “developing customer instincts and building commercial muscle”... View Details
Keywords: Susan Young
- 01 Jun 2024
- News
Decoding the Promise and Perils of Generative AI
ChatGPT burst into the public consciousness on November 30, 2022. Within two months, the generative artificial intelligence (GenAI) software, which leverages a large language model (LLM) to produce human-like, text-based conversations, had reached an estimated 100... View Details
Keywords: April White
- 10 Oct 2007
- First Look
First Look: First Look: October 10
spending on groceries. Controlling for customer-fixed effects and other relevant variables, we find that grocery spending increases by $1.59 with the use of a $10-off coupon. In addition, even though the receipt of a $10-off coupon does... View Details
Keywords: Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
that firms focusing on a particular task—at either a divisional or firm level—experience higher output and productivity with respect to that task than unfocused firms. After controlling for selection, scale, and learning effects, we find... View Details
Keywords: Sean Silverthorne
- 01 Mar 2013
- News
Making Change
aim to make rigorous impact-measurement approaches, like randomized controlled trials, practical and accessible to practitioners. In India, we are helping the State of Bihar improve a $200 million nutrition... View Details
- 2013
- Working Paper
What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms
By: Amir N. Licht, Christopher Poliquin, Jordan I. Siegel and Xi Li
On March 29, 2010, the U.S. Supreme Court signaled its intention to geographically limit the reach of the U.S. securities antifraud regime and thus differentially exclude U.S.-listed foreign firms from the ambit of formal U.S. antifraud enforcement. We use this legal... View Details
Keywords: Crime and Corruption; International Finance; Investment; Corporate Governance; Governing Rules, Regulations, and Reforms; Courts and Trials; Legal Liability; United States
Licht, Amir N., Christopher Poliquin, Jordan I. Siegel, and Xi Li. "What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms." Harvard Business School Working Paper, No. 11-072, January 2011. (Revised August 2013.)